HLA-DR/CD8 - IMMUNOSTEP. WE KNOW HOW
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: HLA-DR/CD8 - IMMUNOSTEP. WE KNOW HOW
產(chǎn)品型號(hào):
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
HLA-DR/CD8 - IMMUNOSTEP. WE KNOW HOW
HLA-DR/CD8 - IMMUNOSTEP. WE KNOW HOW
的詳細(xì)介紹
FITC/ PE
- anti Human
HLA-DR/CD8 - GRB-1, 33-2A3
-
GRB-1, 33-2A3
-
-
FCM
-
FITC/ PE
-
-
-
Human
-
PBS, 0,09% sodium Azide, may contain carrier protein-stabilizer
-
RUO
-
-
-
Antigen details
The HLA-DR/CD8 is used for indentification of T lymphocytes CD8+/HLA-DR+. Elevated levels of CD8+/HLA-DR+ T lymphocytes are observed in human immunodeficiency virus (HIV) infection and during the acute stages of Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection. In HIV infection, the coexpression of CD8 andCD38, with a concomitant low percentage of CD4+ lymphocytes, is closely associated with disease progression. Selective elevation of HLA-DR+/CD38-/CD8+ cells may be a marker of stable HIV disease.
